Drug: |
PLX3397 + Pembrolizumab |
|||
---|---|---|---|---|
Trial: |
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
Marin Cancer Institute1350 S Eliseo Dr # 100 |
Principal Investigator: |
|
---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Marin Cancer Institute Website: |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.